HOME › DRUGS › SITAGLIPTIN FUMARATE
ACTIVE SUBSTANCE / INN

SITAGLIPTIN FUMARATE

Brand name(s): Sitagliptin SUN
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Sitagliptin Fumarate
REGULATORS
EMA
SPONSORS / MAH
Sun Pharmaceutical Industries Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Sitagliptin SUNSun Pharmaceutical Industries Europe B.V.Authorised09/12/2021Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON SITAGLIPTIN FUMARATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →